Study of Benralizumab in People With Skin Side Effects Caused by Cancer Therapies
Status:
Recruiting
Trial end date:
2022-03-16
Target enrollment:
Participant gender:
Summary
The purpose of this study is to find out whether the study drug benralizumab is a safe
treatment that can reduce the skin side effects caused by cancer treatment by reducing the
level of eosinophils in your blood. Reducing the skin side effects of your cancer treatment
may improve quality of life and allow participants to continue to receive their usual cancer
treatment.